PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
75.69%
Positive revenue growth while 1097.HK is negative. John Neff might see a notable competitive edge here.
187.44%
Positive gross profit growth while 1097.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
1.81%
Positive operating income growth while 1097.HK is negative. John Neff might view this as a competitive edge in operations.
-4.44%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
Share reduction more than 1.5x 1097.HK's 46.00%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-23.07%
Negative OCF growth while 1097.HK is at 680.17%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-58.48%
Negative FCF growth while 1097.HK is at 84.82%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-83.82%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
51804.85%
Positive 5Y CAGR while 1097.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
2575.51%
Positive 3Y CAGR while 1097.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-146.22%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-138.24%
Negative 5Y OCF/share CAGR while 1097.HK is at 26.92%. Joel Greenblatt would question the firm’s operational model or cost structure.
31.75%
Positive 3Y OCF/share CAGR while 1097.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-804.83%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-742.20%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-307.69%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
176.96%
Positive 5Y equity/share CAGR while 1097.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
6.27%
Positive short-term equity growth while 1097.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Negative near-term dividend growth while 1097.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
36.39%
Inventory growth well above 1097.HK's 27.40%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.81%
Negative asset growth while 1097.HK invests at 6.35%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-6.06%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
444.00%
Debt growth far above 1097.HK's 42.17%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.